C4 Therapeutics


C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.






Org chart

Andrew Hirsch
President & CEO

Andrew Hirsch

Scott Boyle
Chief Business Officer
Len Reyno
Chief Medical Officer
Stew Fisher
Chief Scientific Officer
Kelly Schick
Chief People Officer
Stewart L. Fisher
Chief Scientific Officer
Mark Mossler
Chief Accounting Officer
Jolie Siegel
Chief Legal Officer
Kendra Adams
SVP, Communications & IR
Mary Christian
SVP, Regulatory
Mike Garcia-Webb
Vp, Development Program Lead
Mayra Reyes-Armour
VP, Technical Operations
Robert Bruno
Vice President, CMC And Supply Chain
Adrian Bignami
Vice President Of Finance, Business Planning And Analysis
Matthew Forti
Head Of Facilities
Mary Lee Fleishell
Sr. Director Contracts & Intellectual Property
Amy Seidel
Senior Director Drug Safety And Pharmacovigilance
Anna G. Maione
Director, Portfolio & Program Management
Karson Kump
Director, Corporate Development